欧洲生物药品肥胖创新论坛在莱比锡启动,重点是肥胖症治疗创新。 
The European Biopharma Obesity Innovation Forum launches in Leipzig, focusing on obesity treatment innovations.
欧洲生物药物肥胖创新论坛将于2025年6月11日至12日在德国莱比锡启动。 The European Biopharma Obesity Innovation Forum (EBOIF) will launch in Leipzig, Germany, from June 11-12, 2025. 这次活动将生物技术、制药、学术和投资部门聚集在一起,探讨肥胖症治疗创新。 This event brings together biotech, pharma, academic, and investment sectors to explore obesity treatment innovations. 来自全球各地的约150名与会者,论坛将讨论市场潜力、生物制药交易和下一代治疗等议题。 With about 150 participants from around the globe, the forum will cover topics like market potential, biopharma dealmaking, and next-gen therapeutics. Leipzig以其研究机构著称,将于6月18日和19日举行虚拟会议,以便利国际参与。 Leipzig, known for its research institutions, is the venue, and virtual sessions will be held on June 18 and 19 to facilitate international participation.
